IDLDX — IDL Diagnostics AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK78.32m
- SEK55.16m
- SEK53.11m
Brief: AroCell Expands Its Presence In Chinese Market
Brief: AroCell Signs Distributor Agreement In India
Brief: Arocell Q2 Loss After Financial Items Widens To SEK 16.0 Million
Brief: AroCell's UBC Rapid Verified For Use On New Instrument
Brief: Arocell Q1 Loss After Financial Items Widens To SEK 15.7 Mln
Brief: AroCell Appoints Ellen Dittberner As New CFO
Brief: AroCell Signs New Distribution Agreement In Kenya
Brief: Arocell Proposes New Election Of Johan Häggblad As Chairman Of Board
Brief: Arocell Carries Out Directed Issue Of Shares To Guarantors
Brief: AroCell Q4 Loss Before Financial Items Widens To SEK 20.0 Mln
Brief: Arocell Raises SEK 86 Million Through Rights Issue
Brief: Arocell Starts Talks With New Partner On Collaboration
Brief: Arocell Enters Into Partnership With Zecen Biotech For Distribution In China
Brief: Arocell Proposes Rights Issue Of Approximately SEK 86 Mln
Brief: AroCell Signs New Distributor Agreement In The UK
Brief: Arocell Q3 Loss After Financial Items Widens To SEK 19 Mln
Brief: AroCell: New Results With TK 210 ELISA Support Early Therapy Response In Breast Cancer
Brief: Arocell Q2 Pretax Loss Widens To SEK 6.7 Mln
Brief: AroCell Study Shows Elevated Levels Of Serum TK1 In Hodgkin Lymphoma Patients